
1. j viral hepat. 2018 mar;25(3):254-261. doi: 10.1111/jvh.12812. epub 2017 dec 19.

lower levels dehydroepiandrosterone sulfate associated advanced 
liver fibrosis chronic hepatitis c.

de araujo neto jm(1), coelho hsm(1), chindamo mc(1), rezende gfm(1), nunes
pannain vl(2), bottino amcf(2), bruzzi porto lf(3), luiz rr(4), villela-nogueira 
ca(1), perez rm(1)(3)(5).

author information: 
(1)internal medicine department, hepatology division, federal university rio
de janeiro, rio de janeiro, brazil.
(2)pathology department, federal university rio de janeiro, rio de janeiro,
brazil.
(3)d'or institute research education (idor), rio de janeiro, brazil.
(4)federal university rio de janeiro, public health institute, rio de janeiro,
brazil.
(5)gastroenterology department, university state rio de janeiro, rio de
janeiro, brazil.

chronic infection hepatitis c virus induces liver fibrosis, is
unknown patients progress advanced fibrosis others remain 
mild disease. recently, inverse association serum levels of
dehydroepiandrosterone sulphate (dhea-s) liver fibrosis patients with
nonalcoholic fatty liver disease described, postulated that
dehydroepiandrosterone (dhea) antifibrotic effects. aim compare
serum dhea-s levels liver fibrosis hepatitis c patients. collected
serum samples hepatitis c patients day underwent liver
biopsy. s-dhea compared different stages fibrosis. binary logistic
regression models applied evaluate independent variables associated to
fibrosis. included 287 patients (43.9% male). according fibrosis stages 0, 
1, 2, 3 4, median serum dhea-s levels 103 (26-462), 73 (5-391), 46
(4-425), 35 (6-292) 28 (2-115) μg/dl, respectively (p < .001). median serum
dhea-s levels 74 (5-462) vs 36 (2-425) μg/dl mild (f0-1) vs significant 
(f2-4) fibrosis, respectively (p < .001). median serum dhea-s levels 64
(4-462) vs 31 (2-292) μg/dl non advanced (f0-2) vs advanced fibrosis (f3-4), 
respectively (p < .001). association found subgroup hcv 
patients without steatosis steatohepatitis analysed. the
association lower dhea-s levels advanced fibrosis independent 
age, gender, diabetes mellitus, obesity steatosis. lower circulating dhea-s
levels associated advanced stages liver fibrosis hepatitis c 
patients.

© 2017 john wiley & sons ltd.

doi: 10.1111/jvh.12812 
pmid: 29091323  [indexed medline]

